American Healthcare REIT (NYSE:AHR - Get Free Report) had its target price raised by investment analysts at JMP Securities from $40.00 to $45.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a "market outperform" rating on the stock. JMP Securities' price target would indicate a potential upside of 11.16% from the stock's previous close.
Other research analysts have also issued research reports about the stock. Morgan Stanley raised their price target on shares of American Healthcare REIT from $37.00 to $45.00 and gave the company an "overweight" rating in a report on Tuesday, May 20th. Baird R W raised shares of American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. Jefferies Financial Group initiated coverage on American Healthcare REIT in a report on Monday, April 28th. They issued a "buy" rating and a $37.00 target price on the stock. Scotiabank initiated coverage on American Healthcare REIT in a report on Monday, June 30th. They issued a "sector outperform" rating and a $42.00 target price on the stock. Finally, KeyCorp upped their target price on American Healthcare REIT from $34.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, June 11th. Ten analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $40.44.
Check Out Our Latest Stock Report on AHR
American Healthcare REIT Price Performance
Shares of NYSE:AHR traded up $0.09 during midday trading on Monday, hitting $40.48. The company's stock had a trading volume of 688,550 shares, compared to its average volume of 1,633,916. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.38 and a current ratio of 0.48. The business's 50 day simple moving average is $37.33 and its 200 day simple moving average is $32.99. American Healthcare REIT has a 12-month low of $18.49 and a 12-month high of $41.50. The company has a market cap of $6.46 billion, a P/E ratio of -184.00, a price-to-earnings-growth ratio of 2.26 and a beta of 1.08.
American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.02. The company had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. American Healthcare REIT's quarterly revenue was up 7.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.33 earnings per share. On average, analysts forecast that American Healthcare REIT will post 1.41 EPS for the current year.
Insiders Place Their Bets
In other American Healthcare REIT news, CIO Stefan K.L. Oh sold 3,860 shares of the company's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the transaction, the executive owned 95,671 shares of the company's stock, valued at $3,453,723.10. This represents a 3.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.92% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On American Healthcare REIT
A number of hedge funds have recently added to or reduced their stakes in the company. MML Investors Services LLC raised its stake in shares of American Healthcare REIT by 7.6% in the second quarter. MML Investors Services LLC now owns 23,684 shares of the company's stock valued at $870,000 after buying an additional 1,677 shares during the period. Militia Capital Partners LP lifted its stake in shares of American Healthcare REIT by 26.2% in the 2nd quarter. Militia Capital Partners LP now owns 18,800 shares of the company's stock valued at $691,000 after acquiring an additional 3,900 shares during the last quarter. Lazard Asset Management LLC lifted its stake in shares of American Healthcare REIT by 1,488.2% in the 2nd quarter. Lazard Asset Management LLC now owns 36,942 shares of the company's stock valued at $1,357,000 after acquiring an additional 34,616 shares during the last quarter. Engineers Gate Manager LP bought a new stake in shares of American Healthcare REIT in the 2nd quarter valued at about $966,000. Finally, BNP Paribas Financial Markets lifted its stake in shares of American Healthcare REIT by 148.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 22,520 shares of the company's stock valued at $827,000 after acquiring an additional 13,472 shares during the last quarter. Institutional investors and hedge funds own 16.68% of the company's stock.
American Healthcare REIT Company Profile
(
Get Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
See Also

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.